Innovation drives progress. Center for Drug Evaluation and Research (CDER) of FDA has been a strong supporter of innovation in the development of new drugs and biotherapy products. By understanding the mechanismRead More…
Breakthrough! Scientists Have Successfully Reprogrammed T Cells to Improve the Efficacy of Cancer Immunotherapy
In a study published in Nature, scientists from St. Jude’s Children’s Research Hospital and other institutions have developed a new treatment strategy to effectively enhance cancer immunotherapy, which may effectively slow tumorRead More…
A New Antibody is Expected to be Developed as a General Influenza Vaccine
A team of researchers from the United States have found that an antibody that “embeds” influenza virus surface proteins can protect mice from a variety of influenza virus strains and is expectedRead More…
Comprehensive Analysis of Targeted Drugs for Lung Cancer
Incidence of lung cancer Lung cancer has the highest incidence of cancer in the world. According to WHO’ statistics, there are an estimated 18.1 million new cancer patients worldwide in 2018, ofRead More…
Novel Nanotechnology Platform Is Expected to Accelerate the Research in the Field of Stem Cell Transplantation
In a study published in the international journal ACS Nano, scientists from Rutgers University have developed a new nanotechnology. It may accelerate the research in the field of stem cell transplantation andRead More…
How to Develop Immunotherapeutic Drugs?
The high cost of cancer drugs makes it difficult for public and private health care systems to provide patients with up-to-date treatment. If this trend continues, it will be increasingly difficult forRead More…
Antibody Drugs and Cell Therapy for Tumor Microenvironment
According to the World Health Organization (WHO), cancer is the second leading cause of death in the world. In 2018 alone, 9.6 million people worldwide died of cancer, accounting for about 1/6Read More…
Monoclonal Drug Development and Market Conditions
B lymphocytes can only produce a proprietary antibody against an antigen determinant, so it has the characteristics of highly specific physical and chemical properties, single biological activity, strong binding specificity with antigenRead More…
Focus on the Technology Bottleneck of Monoclonal Antibody Drugs
The Antibodies are secreted by plasma cells transformed from B cells, and each B cell line can produce only one specific antigenic determinant. The antibody, produced from a single cell line, isRead More…
Antibodies Cure Guinea Pigs Infected with Ebola Virus, Raising Hopes for Human Treatment of Ebola
The outbreak of Ebola in 2014 in West Africa killed more than 11000 people. At the time, scientists were working on several experimental vaccines and treatments, but none of them were approvedRead More…